“…This striatum-first pattern of Aβ deposition in Down syndrome is consistent with the observations in individuals with autosomal-dominant Alzheimer’s disease and APP duplication ( Bateman et al, 2012 , Klunk et al, 2007 , Remes et al, 2008 , Villemagne et al, 2009 ). Similar to late-onset Alzheimer’s disease, Down syndrome presents identical patterns of cortical Aβ retention ( Annus et al, 2016 , Cole et al, 2017 , Hartley et al, 2014 , Jennings et al, 2015 , Landt et al, 2011 , Lao et al, 2018 , Lao et al, 2016 , Mak et al, 2019 , Matthews et al, 2016 , Rafii et al, 2015 , Rafii et al, 2017 , Sabbagh et al, 2015 ) and shows longitudinal increases of ~3–4% per year, however with a wide variation in the age of Aβ onset ( Lao et al, 2017 , Tudorascu et al, 2019 , Zammit et al, 2020 ). In late-onset Alzheimer’s disease, striatal Aβ retention is observed much later in the disease progression ( Hanseeuw et al, 2018 ) compared to Down syndrome, indicating that the striatum can be used as an early marker of Alzheimer’s disease progression in this population ( Cohen et al, 2018 ).…”